162 related articles for article (PubMed ID: 38186361)
41. Prevention of acute radiodermatitis by photobiomodulation: A randomized, placebo-controlled trial in breast cancer patients (TRANSDERMIS trial).
Robijns J; Censabella S; Claes S; Pannekoeke L; Bussé L; Colson D; Kaminski I; Bulens P; Maes A; Noé L; Brosens M; Timmermans A; Lambrichts I; Somers V; Mebis J
Lasers Surg Med; 2018 Feb; ():. PubMed ID: 29427390
[TBL] [Abstract][Full Text] [Related]
42. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
[TBL] [Abstract][Full Text] [Related]
43. Mepitel Film for the Prevention of Acute Radiation Dermatitis in Breast Cancer: A Randomized Multicenter Open-Label Phase III Trial.
Behroozian T; Milton L; Karam I; Zhang L; Ding K; Lou J; Gallant F; Rakovitch E; Tran W; Soliman H; Leung E; Vesprini D; Szumacher E; Chen H; Donovan E; Lam J; Spadafora S; Wronski M; Lavoie C; Walde N; Lam E; Wong G; McKenzie E; Ariello K; Kennedy S; Shariati S; Carothers K; Gonzales G; Kagan Y; Chow E
J Clin Oncol; 2023 Feb; 41(6):1250-1264. PubMed ID: 36493331
[TBL] [Abstract][Full Text] [Related]
44. Radiation-induced skin changes after breast or chest wall irradiation in patients with breast cancer and skin of color: a systematic review.
Purswani JM; Nwankwo C; Adotama P; Gutierrez D; Perez CA; Tattersall IW; Gerber NK
Clin Breast Cancer; 2023 Jan; 23(1):1-14. PubMed ID: 36335037
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial.
Zhao H; Zhu W; Zhao X; Li X; Zhou Z; Zheng M; Meng X; Kong L; Zhang S; He D; Xing L; Yu J
JAMA Dermatol; 2022 Jul; 158(7):779-786. PubMed ID: 35648426
[TBL] [Abstract][Full Text] [Related]
46. Hydrosorb® versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicentre controlled randomized trial.
Bazire L; Fromantin I; Diallo A; de la Lande B; Pernin V; Dendale R; Fourquet A; Savignoni A; Kirova YM
Radiother Oncol; 2015 Nov; 117(2):229-33. PubMed ID: 26328937
[TBL] [Abstract][Full Text] [Related]
47. Preventing the acute skin side effects in patients treated with radiotherapy for breast cancer: the use of corneometry in order to evaluate the protective effect of moisturizing creams.
Di Franco R; Sammarco E; Calvanese MG; De Natale F; Falivene S; Di Lecce A; Giugliano FM; Murino P; Manzo R; Cappabianca S; Muto P; Ravo V
Radiat Oncol; 2013 Mar; 8():57. PubMed ID: 23497676
[TBL] [Abstract][Full Text] [Related]
48. A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy.
Long X; Guo J; Yin Y; Cheng M; Zhang X; Zhang J; Wang P; Zang J; Zhao L
Radiat Oncol; 2023 Oct; 18(1):174. PubMed ID: 37891689
[TBL] [Abstract][Full Text] [Related]
49. Oral curcumin for radiation dermatitis: a URCC NCORP study of 686 breast cancer patients.
Ryan Wolf J; Heckler CE; Guido JJ; Peoples AR; Gewandter JS; Ling M; Vinciguerra VP; Anderson T; Evans L; Wade J; Pentland AP; Morrow GR
Support Care Cancer; 2018 May; 26(5):1543-1552. PubMed ID: 29192329
[TBL] [Abstract][Full Text] [Related]
50. Symptom Burden Associated With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy.
Milton L; Behroozian T; Li N; Zhang L; Lou J; Karam I; Wronski M; McKenzie E; Mawdsley G; Razvi Y; Chow E; Ruschin M
Clin Breast Cancer; 2022 Apr; 22(3):e387-e398. PubMed ID: 34810145
[TBL] [Abstract][Full Text] [Related]
51. A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis.
Gil GOB; de Andrade WP; Diniz PHC; Cantidio FS; Queiroz IN; Gil MLBV; Almeida CAM; Caldeira PPR; Regalin M; Silva-Filho AL
Front Oncol; 2023; 13():1202544. PubMed ID: 37388233
[TBL] [Abstract][Full Text] [Related]
52. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
53. Retrospective study of radiotherapy-induced skin reactions in breast cancer patients: reduced incidence of moist desquamation with a hydroactive colloid gel versus dexpanthenol.
Censabella S; Claes S; Orlandini M; Braekers R; Thijs H; Bulens P
Eur J Oncol Nurs; 2014 Oct; 18(5):499-504. PubMed ID: 24877859
[TBL] [Abstract][Full Text] [Related]
54. Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis.
Chosidow O; Maurette C; Dupuy P
Dermatology; 2003; 206(3):233-40. PubMed ID: 12673081
[TBL] [Abstract][Full Text] [Related]
55. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
[TBL] [Abstract][Full Text] [Related]
56. Instruments to Evaluate Self-Management of Radiation Dermatitis in Patients With Breast Cancer.
Pembroke M; Nemeth LS
Oncol Nurs Forum; 2020 Jan; 47(1):101-111. PubMed ID: 31845919
[TBL] [Abstract][Full Text] [Related]
57. Predictive factors associated with radiation dermatitis in breast cancer.
Behroozian T; Milton L; Li N; Zhang L; Lou J; Karam I; Wronski M; McKenzie E; Mawdsley G; Razvi Y; Chow E; Ruschin M
Cancer Treat Res Commun; 2021; 28():100403. PubMed ID: 34082363
[TBL] [Abstract][Full Text] [Related]
58. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
[TBL] [Abstract][Full Text] [Related]
59. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13.
Fisher J; Scott C; Stevens R; Marconi B; Champion L; Freedman GM; Asrari F; Pilepich MV; Gagnon JD; Wong G
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1307-10. PubMed ID: 11121627
[TBL] [Abstract][Full Text] [Related]
60. Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.
Sekiguchi K; Ogita M; Akahane K; Haga C; Ito R; Arai S; Ishida Y; Tsukada Y; Kawamori J
Jpn J Clin Oncol; 2015 Dec; 45(12):1146-53. PubMed ID: 26491204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
